Similar articles

• QuantiFERON-TB Gold In-tube test for the diagnosis of active and latent tuberculosis in selected health facilities of Addis Ababa, Ethiopia.

  Niguse S, Desta K, Gebremichael G, Gebrezgeaxier A, Getahun M, Kassa D. Niguse S, et al. BMC Res Notes. 2018 May 11;11(1):293. doi: 10.1186/s13104-018-3410-x. BMC Res Notes. 2018. PMID: 29751780 Free PMC article.
• Discordance between the QuantiFERON-TB Gold In-Tube and Tuberculin Skin Test: need for a further step?

  Spinicci M, Mencarini J, Goletti D, Mantella A, Della Malva N, Bartoloni A, Bartalesi F. Spinicci M, et al. Eur Respir J. 2015 Nov;46(5):1506-9. doi: 10.1183/13993003.00403-2015. Epub 2015 Jul 23. Eur Respir J. 2015. PMID: 26206879 No abstract available.
• The journey from latent to active TB: no roadmaps as yet.

  Khurana AK, Khurana U. Khurana AK, et al. Chest. 2012 Sep;142(3):811. doi: 10.1378/chest.12-1167. Chest. 2012. PMID: 22948596 No abstract available.
• Clinical application of QuantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis.

  Chen G, Wang H, Wang Y. Chen G, et al. Eur J Clin Microbiol Infect Dis. 2020 Apr;39(4):607-612. doi: 10.1007/s10096-019-03768-9. Epub 2019 Nov 30. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31786694 Review.
• IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers.

  Nienhaus A, Ringshausen FC, Costa JT, Schablon A, Tripodi D. Nienhaus A, et al. Expert Rev Anti Infect Ther. 2013 Jan;11(1):37-48. doi: 10.1586/eri.12.150. Expert Rev Anti Infect Ther. 2013. PMID: 23428101 Review.